Wealth Enhancement Advisory Services LLC Acquires 1,207 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Wealth Enhancement Advisory Services LLC raised its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.8% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 155,880 shares of the medical equipment provider’s stock after buying an additional 1,207 shares during the period. Wealth Enhancement Advisory Services LLC’s holdings in Intuitive Surgical were worth $76,579,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also recently made changes to their positions in the business. Creekmur Asset Management LLC raised its position in Intuitive Surgical by 200.0% in the 1st quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 42 shares during the last quarter. Ridgewood Investments LLC bought a new position in shares of Intuitive Surgical during the second quarter valued at about $26,000. Delos Wealth Advisors LLC boosted its holdings in Intuitive Surgical by 380.0% during the first quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 57 shares during the last quarter. Godsey & Gibb Inc. grew its position in Intuitive Surgical by 140.0% in the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 35 shares in the last quarter. Finally, LRI Investments LLC purchased a new stake in Intuitive Surgical in the 1st quarter valued at about $30,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other Intuitive Surgical news, EVP Brian Edward Miller sold 2,553 shares of the company’s stock in a transaction on Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total value of $1,314,795.00. Following the completion of the transaction, the executive vice president now directly owns 7,066 shares in the company, valued at approximately $3,638,990. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, Director Amal M. Johnson sold 2,943 shares of the business’s stock in a transaction that occurred on Thursday, August 1st. The stock was sold at an average price of $443.30, for a total value of $1,304,631.90. Following the sale, the director now directly owns 12,275 shares of the company’s stock, valued at $5,441,507.50. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, EVP Brian Edward Miller sold 2,553 shares of the firm’s stock in a transaction that occurred on Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total value of $1,314,795.00. Following the transaction, the executive vice president now directly owns 7,066 shares of the company’s stock, valued at approximately $3,638,990. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 52,192 shares of company stock valued at $25,398,571. Company insiders own 0.90% of the company’s stock.

Intuitive Surgical Price Performance

Intuitive Surgical stock traded down $0.36 during trading hours on Friday, reaching $511.27. The stock had a trading volume of 982,549 shares, compared to its average volume of 1,266,059. The company has a fifty day simple moving average of $487.98 and a 200-day simple moving average of $442.31. Intuitive Surgical, Inc. has a 52 week low of $254.85 and a 52 week high of $523.34. The stock has a market cap of $182.10 billion, a PE ratio of 82.20, a PEG ratio of 5.11 and a beta of 1.39.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on ISRG. The Goldman Sachs Group set a $604.00 price objective on Intuitive Surgical in a research note on Friday, October 18th. Truist Financial lifted their price objective on shares of Intuitive Surgical from $520.00 to $570.00 and gave the stock a “buy” rating in a research report on Monday, October 14th. Morgan Stanley increased their target price on shares of Intuitive Surgical from $375.00 to $460.00 and gave the company an “equal weight” rating in a research report on Monday, July 15th. Wells Fargo & Company raised their price target on shares of Intuitive Surgical from $466.00 to $549.00 and gave the stock an “overweight” rating in a research note on Friday, October 18th. Finally, Barclays increased their price objective on Intuitive Surgical from $430.00 to $490.00 and gave the company an “overweight” rating in a report on Thursday, July 18th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Intuitive Surgical presently has an average rating of “Moderate Buy” and an average price target of $513.74.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.